| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Inflammasomes | 8 | 2020 | 710 | 1.29 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 5 | 2019 | 581 | 0.95 | Why? |
| Competitive Bidding | 1 | 2018 | 1 | 0.79 | Why? |
| Purchasing, Hospital | 1 | 2018 | 3 | 0.79 | Why? |
| Liver Failure | 1 | 2020 | 266 | 0.65 | Why? |
| Inflammation | 18 | 2021 | 13255 | 0.65 | Why? |
| Common Variable Immunodeficiency | 5 | 2017 | 195 | 0.63 | Why? |
| Osteoprotegerin | 4 | 2018 | 32 | 0.62 | Why? |
| Ventricular Remodeling | 3 | 2018 | 349 | 0.61 | Why? |
| Fasting | 2 | 2020 | 555 | 0.59 | Why? |
| Atherosclerosis | 3 | 2019 | 768 | 0.58 | Why? |
| Ventricular Function, Left | 7 | 2018 | 1555 | 0.58 | Why? |
| Myocardial Infarction | 6 | 2019 | 3361 | 0.58 | Why? |
| Darbepoetin alfa | 3 | 2018 | 10 | 0.57 | Why? |
| Islam | 1 | 2020 | 545 | 0.52 | Why? |
| Myocardium | 4 | 2019 | 2323 | 0.51 | Why? |
| Biomarkers | 40 | 2021 | 23361 | 0.50 | Why? |
| Non-ST Elevated Myocardial Infarction | 4 | 2018 | 490 | 0.48 | Why? |
| Inflammation Mediators | 7 | 2019 | 2654 | 0.48 | Why? |
| Diabetes, Gestational | 4 | 2019 | 426 | 0.48 | Why? |
| Chemokine CCL21 | 3 | 2019 | 5 | 0.45 | Why? |
| Gastrointestinal Microbiome | 6 | 2020 | 1961 | 0.44 | Why? |
| Schizophrenia | 5 | 2019 | 1018 | 0.43 | Why? |
| Antigens, CD | 6 | 2020 | 984 | 0.41 | Why? |
| Coronary Artery Disease | 6 | 2019 | 2570 | 0.41 | Why? |
| Serum Amyloid P-Component | 4 | 2019 | 193 | 0.41 | Why? |
| Monocytes | 7 | 2019 | 2978 | 0.41 | Why? |
| Carotid Artery Diseases | 3 | 2018 | 251 | 0.40 | Why? |
| Leukocytes, Mononuclear | 6 | 2019 | 2115 | 0.40 | Why? |
| Intercellular Signaling Peptides and Proteins | 4 | 2019 | 245 | 0.40 | Why? |
| Gene Expression | 9 | 2019 | 3332 | 0.39 | Why? |
| Acute Coronary Syndrome | 6 | 2019 | 2107 | 0.39 | Why? |
| Fibroblasts | 3 | 2019 | 839 | 0.38 | Why? |
| Heart Failure | 12 | 2019 | 6638 | 0.38 | Why? |
| Bipolar Disorder | 4 | 2018 | 744 | 0.38 | Why? |
| Norway | 8 | 2021 | 1004 | 0.38 | Why? |
| Cardiomyopathy, Dilated | 3 | 2017 | 251 | 0.38 | Why? |
| Stroke Volume | 5 | 2018 | 2153 | 0.37 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2012 | 365 | 0.37 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2018 | 229 | 0.35 | Why? |
| Wnt-5a Protein | 2 | 2017 | 14 | 0.35 | Why? |
| Extracellular Matrix | 3 | 2018 | 189 | 0.34 | Why? |
| Natriuretic Peptide, Brain | 7 | 2020 | 1215 | 0.34 | Why? |
| Islets of Langerhans | 2 | 2018 | 138 | 0.33 | Why? |
| Signal Transduction | 9 | 2019 | 7207 | 0.32 | Why? |
| Platelet Aggregation Inhibitors | 3 | 2019 | 1671 | 0.32 | Why? |
| Anemia | 3 | 2018 | 789 | 0.32 | Why? |
| Carotid Arteries | 3 | 2017 | 182 | 0.31 | Why? |
| Receptors, Interleukin-6 | 3 | 2018 | 1383 | 0.31 | Why? |
| Adiponectin | 2 | 2017 | 123 | 0.31 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.30 | Why? |
| Troponin T | 4 | 2019 | 771 | 0.29 | Why? |
| Hyperlipoproteinemia Type II | 2 | 2017 | 123 | 0.29 | Why? |
| Chemokines | 3 | 2006 | 1095 | 0.29 | Why? |
| Ticlopidine | 1 | 2006 | 193 | 0.28 | Why? |
| Plaque, Atherosclerotic | 6 | 2018 | 423 | 0.28 | Why? |
| T-Lymphocytes | 7 | 2020 | 6670 | 0.27 | Why? |
| C-Reactive Protein | 10 | 2020 | 7972 | 0.27 | Why? |
| Gene Expression Regulation | 6 | 2019 | 4020 | 0.26 | Why? |
| Chemokines, CXC | 1 | 2003 | 68 | 0.25 | Why? |
| Macrophages | 7 | 2019 | 2784 | 0.25 | Why? |
| Chemokine CCL19 | 2 | 2019 | 22 | 0.24 | Why? |
| Lipoproteins, LDL | 1 | 2003 | 115 | 0.24 | Why? |
| Neopterin | 3 | 2018 | 69 | 0.23 | Why? |
| Scleroderma, Systemic | 2 | 2018 | 583 | 0.23 | Why? |
| Interleukin-1beta | 4 | 2020 | 992 | 0.23 | Why? |
| Obesity | 2 | 2019 | 7388 | 0.23 | Why? |
| Antigens, Differentiation, Myelomonocytic | 2 | 2020 | 198 | 0.22 | Why? |
| IgA Deficiency | 2 | 2019 | 36 | 0.22 | Why? |
| Carrier Proteins | 3 | 2020 | 513 | 0.22 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2019 | 6166 | 0.22 | Why? |
| DNA Damage | 3 | 2017 | 285 | 0.21 | Why? |
| Chemokines, CC | 1 | 2020 | 79 | 0.21 | Why? |
| Electrocardiography | 3 | 2018 | 3957 | 0.21 | Why? |
| Complement Factor B | 1 | 2019 | 36 | 0.21 | Why? |
| Heart Transplantation | 3 | 2019 | 1293 | 0.21 | Why? |
| Mitochondria, Muscle | 1 | 2019 | 8 | 0.21 | Why? |
| Toll-Like Receptor 9 | 2 | 2017 | 72 | 0.20 | Why? |
| Tryptophan | 2 | 2018 | 218 | 0.20 | Why? |
| Betaine | 1 | 2019 | 16 | 0.20 | Why? |
| Aortic Valve Stenosis | 2 | 2019 | 741 | 0.20 | Why? |
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2020 | 98 | 0.20 | Why? |
| Methylamines | 1 | 2019 | 23 | 0.20 | Why? |
| Antibodies, Monoclonal, Humanized | 5 | 2020 | 9335 | 0.20 | Why? |
| Everolimus | 2 | 2019 | 215 | 0.20 | Why? |
| Fatty Acids, Omega-6 | 1 | 2019 | 43 | 0.20 | Why? |
| Gastrin-Releasing Peptide | 1 | 2018 | 1 | 0.20 | Why? |
| CX3C Chemokine Receptor 1 | 1 | 2018 | 21 | 0.20 | Why? |
| Carnitine | 1 | 2019 | 47 | 0.20 | Why? |
| Tumor Necrosis Factor-alpha | 3 | 2019 | 2483 | 0.20 | Why? |
| Nuclear Receptor Co-Repressor 1 | 1 | 2018 | 4 | 0.19 | Why? |
| Saccharomyces boulardii | 1 | 2018 | 5 | 0.19 | Why? |
| Case-Control Studies | 17 | 2020 | 17671 | 0.19 | Why? |
| Receptor, Anaphylatoxin C5a | 2 | 2018 | 77 | 0.19 | Why? |
| Fetal Proteins | 1 | 2018 | 5 | 0.19 | Why? |
| Chemokine CX3CL1 | 1 | 2018 | 26 | 0.19 | Why? |
| Receptors, Interleukin-1 Type II | 1 | 2018 | 2 | 0.19 | Why? |
| Insulin Resistance | 3 | 2019 | 669 | 0.19 | Why? |
| Male | 75 | 2021 | 367725 | 0.19 | Why? |
| Cell Adhesion Molecules, Neuronal | 1 | 2018 | 12 | 0.19 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2020 | 211 | 0.19 | Why? |
| Insulin-Secreting Cells | 2 | 2018 | 273 | 0.19 | Why? |
| Interleukin-8 | 2 | 2017 | 964 | 0.19 | Why? |
| Parasitemia | 1 | 2018 | 88 | 0.19 | Why? |
| NAD | 1 | 2019 | 73 | 0.19 | Why? |
| Female | 76 | 2021 | 380317 | 0.19 | Why? |
| Leptin | 2 | 2017 | 141 | 0.19 | Why? |
| Intramolecular Oxidoreductases | 1 | 2018 | 38 | 0.18 | Why? |
| Aryldialkylphosphatase | 1 | 2018 | 61 | 0.18 | Why? |
| Heart Failure, Systolic | 1 | 2018 | 39 | 0.18 | Why? |
| Macrophage Migration-Inhibitory Factors | 1 | 2018 | 39 | 0.18 | Why? |
| Interleukin-27 | 1 | 2017 | 10 | 0.18 | Why? |
| Receptors, Chemokine | 1 | 2018 | 56 | 0.18 | Why? |
| Middle Aged | 62 | 2021 | 270681 | 0.18 | Why? |
| Wnt Proteins | 1 | 2018 | 38 | 0.18 | Why? |
| Chemokine CXCL16 | 1 | 2017 | 7 | 0.18 | Why? |
| Chemokine CCL2 | 1 | 2020 | 389 | 0.18 | Why? |
| Chemokine CCL4 | 1 | 2018 | 71 | 0.18 | Why? |
| Receptors, Adiponectin | 1 | 2017 | 6 | 0.18 | Why? |
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2018 | 51 | 0.18 | Why? |
| Familial Primary Pulmonary Hypertension | 1 | 2018 | 68 | 0.18 | Why? |
| Receptors, Notch | 1 | 2018 | 59 | 0.18 | Why? |
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2018 | 29 | 0.18 | Why? |
| Adipokines | 1 | 2019 | 87 | 0.18 | Why? |
| Humans | 101 | 2021 | 930598 | 0.18 | Why? |
| Cartilage Oligomeric Matrix Protein | 1 | 2017 | 3 | 0.18 | Why? |
| Fetal Macrosomia | 1 | 2017 | 16 | 0.18 | Why? |
| Interleukin-6 | 4 | 2020 | 7522 | 0.18 | Why? |
| Receptors, Cell Surface | 2 | 2020 | 586 | 0.18 | Why? |
| Fatty Acids, Omega-3 | 2 | 2017 | 306 | 0.18 | Why? |
| Scavenger Receptors, Class E | 1 | 2018 | 50 | 0.18 | Why? |
| Cyclosporine | 2 | 2019 | 449 | 0.17 | Why? |
| Cyclodextrins | 1 | 2017 | 24 | 0.17 | Why? |
| GATA2 Transcription Factor | 1 | 2017 | 13 | 0.17 | Why? |
| Interferon beta-1a | 1 | 2020 | 316 | 0.17 | Why? |
| Chitinase-3-Like Protein 1 | 1 | 2017 | 28 | 0.17 | Why? |
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2017 | 55 | 0.17 | Why? |
| Epistaxis | 1 | 2018 | 96 | 0.17 | Why? |
| Peptide Fragments | 5 | 2020 | 2075 | 0.17 | Why? |
| Lipoprotein(a) | 1 | 2018 | 92 | 0.17 | Why? |
| N-Glycosyl Hydrolases | 1 | 2017 | 19 | 0.17 | Why? |
| Air Pollutants, Occupational | 1 | 2018 | 108 | 0.17 | Why? |
| Aged | 50 | 2020 | 215776 | 0.17 | Why? |
| Calcineurin Inhibitors | 1 | 2018 | 218 | 0.17 | Why? |
| Complement Pathway, Alternative | 1 | 2017 | 35 | 0.17 | Why? |
| Lymphocyte Activation | 5 | 2020 | 2742 | 0.16 | Why? |
| Cardiac Resynchronization Therapy | 1 | 2019 | 191 | 0.16 | Why? |
| Lipocalin-2 | 1 | 2018 | 156 | 0.16 | Why? |
| Infrared Rays | 1 | 2017 | 127 | 0.16 | Why? |
| Bile Acids and Salts | 1 | 2017 | 91 | 0.16 | Why? |
| Central Nervous System Infections | 1 | 2018 | 158 | 0.16 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2019 | 385 | 0.16 | Why? |
| Complement System Proteins | 2 | 2017 | 380 | 0.16 | Why? |
| Pregnancy Trimester, First | 1 | 2018 | 366 | 0.16 | Why? |
| Complement Activation | 2 | 2020 | 949 | 0.16 | Why? |
| Cell Cycle Proteins | 1 | 2018 | 297 | 0.16 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2018 | 192 | 0.16 | Why? |
| Transcription Factors | 2 | 2019 | 784 | 0.16 | Why? |
| DNA Repair | 1 | 2016 | 114 | 0.16 | Why? |
| Toll-Like Receptor 4 | 1 | 2019 | 390 | 0.15 | Why? |
| Respiratory Insufficiency | 4 | 2021 | 7301 | 0.15 | Why? |
| Hypertriglyceridemia | 1 | 2017 | 90 | 0.15 | Why? |
| Prediabetic State | 1 | 2018 | 200 | 0.15 | Why? |
| Fetal Development | 1 | 2017 | 173 | 0.15 | Why? |
| Endodeoxyribonucleases | 1 | 2017 | 149 | 0.15 | Why? |
| Lipoproteins | 1 | 2017 | 240 | 0.15 | Why? |
| Prefrontal Cortex | 1 | 2017 | 151 | 0.15 | Why? |
| Cell Proliferation | 4 | 2017 | 1973 | 0.15 | Why? |
| Nuclear Proteins | 1 | 2018 | 321 | 0.15 | Why? |
| Birth Weight | 1 | 2017 | 250 | 0.15 | Why? |
| Interleukin-4 | 1 | 2017 | 367 | 0.15 | Why? |
| Calcium-Binding Proteins | 2 | 2017 | 121 | 0.15 | Why? |
| Aorta | 1 | 2018 | 355 | 0.15 | Why? |
| Bicycling | 1 | 2017 | 133 | 0.15 | Why? |
| ADAM17 Protein | 1 | 2017 | 221 | 0.15 | Why? |
| Up-Regulation | 6 | 2018 | 2249 | 0.15 | Why? |
| Coronary Circulation | 1 | 2017 | 188 | 0.15 | Why? |
| Neutrophils | 3 | 2021 | 5476 | 0.15 | Why? |
| Sleep Apnea Syndromes | 1 | 2019 | 282 | 0.15 | Why? |
| Interleukins | 2 | 2018 | 762 | 0.15 | Why? |
| Cell Adhesion Molecules | 2 | 2017 | 472 | 0.14 | Why? |
| Pre-Eclampsia | 2 | 2017 | 599 | 0.14 | Why? |
| Energy Metabolism | 1 | 2019 | 451 | 0.14 | Why? |
| Lung Diseases, Interstitial | 2 | 2018 | 1476 | 0.14 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.14 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2018 | 801 | 0.14 | Why? |
| Cells, Cultured | 8 | 2019 | 5835 | 0.14 | Why? |
| Fluorobenzenes | 1 | 2014 | 7 | 0.14 | Why? |
| DNA, Mitochondrial | 1 | 2016 | 163 | 0.14 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 800 | 0.14 | Why? |
| Immunoenzyme Techniques | 3 | 2018 | 448 | 0.14 | Why? |
| Mood Disorders | 1 | 2019 | 431 | 0.14 | Why? |
| Hematinics | 3 | 2018 | 48 | 0.14 | Why? |
| Basigin | 1 | 2017 | 276 | 0.14 | Why? |
| Firearms | 1 | 2018 | 238 | 0.14 | Why? |
| Myocardial Reperfusion Injury | 1 | 2015 | 129 | 0.14 | Why? |
| Malaria, Falciparum | 1 | 2018 | 377 | 0.13 | Why? |
| Chemokine CXCL10 | 1 | 2018 | 565 | 0.13 | Why? |
| Intestinal Mucosa | 2 | 2020 | 1046 | 0.13 | Why? |
| Hematopoietic Stem Cells | 1 | 2017 | 321 | 0.13 | Why? |
| Prognosis | 16 | 2021 | 32490 | 0.13 | Why? |
| RNA, Messenger | 5 | 2019 | 5131 | 0.13 | Why? |
| Cytokines | 8 | 2020 | 15010 | 0.13 | Why? |
| Physical Fitness | 1 | 2017 | 334 | 0.13 | Why? |
| Lipids | 2 | 2017 | 1079 | 0.13 | Why? |
| Ischemic Attack, Transient | 1 | 2018 | 439 | 0.13 | Why? |
| Adenosine Monophosphate | 2 | 2021 | 5652 | 0.13 | Why? |
| Alanine | 2 | 2021 | 5687 | 0.13 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.12 | Why? |
| Follow-Up Studies | 11 | 2019 | 17020 | 0.12 | Why? |
| Double-Blind Method | 6 | 2018 | 5988 | 0.12 | Why? |
| Cardiovascular Diseases | 4 | 2019 | 11497 | 0.12 | Why? |
| Tretinoin | 1 | 2013 | 99 | 0.12 | Why? |
| Immunity, Innate | 4 | 2021 | 6570 | 0.12 | Why? |
| Glucose Tolerance Test | 3 | 2018 | 238 | 0.12 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.12 | Why? |
| Adult | 42 | 2020 | 244371 | 0.12 | Why? |
| Muscle, Skeletal | 1 | 2019 | 915 | 0.12 | Why? |
| Endothelium, Vascular | 2 | 2018 | 1751 | 0.12 | Why? |
| Postpartum Period | 1 | 2018 | 936 | 0.11 | Why? |
| Graft Rejection | 2 | 2019 | 1766 | 0.11 | Why? |
| Blood Platelets | 1 | 2003 | 1704 | 0.11 | Why? |
| Metabolic Diseases | 1 | 2017 | 505 | 0.11 | Why? |
| Adjuvants, Immunologic | 1 | 2001 | 1709 | 0.11 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.11 | Why? |
| von Willebrand Factor | 1 | 2017 | 668 | 0.11 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.11 | Why? |
| Extracellular Matrix Proteins | 1 | 2011 | 95 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.11 | Why? |
| Mice, Knockout | 4 | 2019 | 1815 | 0.11 | Why? |
| B-Lymphocytes | 2 | 2017 | 4418 | 0.11 | Why? |
| Celiac Disease | 1 | 2017 | 471 | 0.10 | Why? |
| Spirochaetales Infections | 1 | 1989 | 10 | 0.10 | Why? |
| Oxidative Stress | 2 | 2018 | 2050 | 0.10 | Why? |
| Ventricular Dysfunction, Right | 1 | 2017 | 639 | 0.10 | Why? |
| Continuous Positive Airway Pressure | 1 | 2019 | 1187 | 0.10 | Why? |
| Proctitis | 1 | 1989 | 16 | 0.10 | Why? |
| Risk Factors | 14 | 2019 | 71621 | 0.10 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.10 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2017 | 1510 | 0.10 | Why? |
| Immunoglobulins, Intravenous | 1 | 2001 | 2705 | 0.09 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 1165 | 0.09 | Why? |
| Pancreatitis | 1 | 2017 | 688 | 0.09 | Why? |
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2008 | 41 | 0.09 | Why? |
| Ventricular Dysfunction, Left | 1 | 2017 | 993 | 0.09 | Why? |
| NFATC Transcription Factors | 2 | 2018 | 22 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 4 | 2018 | 3776 | 0.09 | Why? |
| Depressive Disorder, Major | 1 | 2017 | 852 | 0.09 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.09 | Why? |
| Cholesterol, LDL | 3 | 2017 | 499 | 0.09 | Why? |
| Cause of Death | 5 | 2021 | 4823 | 0.09 | Why? |
| Military Personnel | 1 | 2018 | 1097 | 0.09 | Why? |
| Leukemia Inhibitory Factor | 1 | 2006 | 4 | 0.08 | Why? |
| Kynurenine | 2 | 2018 | 140 | 0.08 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.08 | Why? |
| Angina, Unstable | 1 | 2008 | 110 | 0.08 | Why? |
| Sarcomeres | 1 | 2006 | 7 | 0.08 | Why? |
| Wnt Signaling Pathway | 2 | 2018 | 87 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.08 | Why? |
| Psychotic Disorders | 1 | 2017 | 924 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.08 | Why? |
| Activins | 1 | 2006 | 26 | 0.08 | Why? |
| Adaptive Immunity | 1 | 2019 | 2585 | 0.08 | Why? |
| Prospective Studies | 11 | 2020 | 43301 | 0.08 | Why? |
| Interleukin-18 | 2 | 2020 | 328 | 0.08 | Why? |
| Hyperglycemia | 1 | 2018 | 1363 | 0.08 | Why? |
| Microarray Analysis | 2 | 2018 | 262 | 0.08 | Why? |
| Killer Cells, Natural | 1 | 2017 | 2093 | 0.08 | Why? |
| Obesity, Morbid | 1 | 2017 | 1340 | 0.08 | Why? |
| Cardiopulmonary Bypass | 1 | 2008 | 158 | 0.08 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.08 | Why? |
| Injections, Subcutaneous | 2 | 2018 | 647 | 0.08 | Why? |
| Time Factors | 10 | 2020 | 31397 | 0.08 | Why? |
| Macrophage Activation | 2 | 2018 | 315 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
| Pyrimidines | 1 | 2014 | 1557 | 0.08 | Why? |
| Hypothermia, Induced | 1 | 2008 | 176 | 0.07 | Why? |
| Rosuvastatin Calcium | 2 | 2017 | 89 | 0.07 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.07 | Why? |
| Mice | 7 | 2019 | 21357 | 0.07 | Why? |
| Sulfonamides | 1 | 2014 | 1294 | 0.07 | Why? |
| Chronic Disease | 5 | 2019 | 5139 | 0.07 | Why? |
| Arthritis, Rheumatoid | 1 | 2018 | 2043 | 0.07 | Why? |
| Kaplan-Meier Estimate | 3 | 2020 | 4260 | 0.07 | Why? |
| Animals | 10 | 2019 | 78931 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2019 | 2320 | 0.07 | Why? |
| Kidney | 2 | 2017 | 3648 | 0.07 | Why? |
| Lipopolysaccharides | 2 | 2019 | 848 | 0.07 | Why? |
| Chemotactic Factors | 1 | 2003 | 14 | 0.07 | Why? |
| Chemokine CXCL1 | 1 | 2003 | 14 | 0.07 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.07 | Why? |
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 502 | 0.07 | Why? |
| Chemokine CXCL5 | 1 | 2003 | 15 | 0.07 | Why? |
| Lymphocytes | 1 | 2016 | 3056 | 0.06 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.06 | Why? |
| Arteriosclerosis | 1 | 2003 | 50 | 0.06 | Why? |
| Young Adult | 13 | 2019 | 93724 | 0.06 | Why? |
| Adolescent | 13 | 2019 | 86841 | 0.06 | Why? |
| Placebos | 1 | 2006 | 629 | 0.06 | Why? |
| Immunosuppressive Agents | 2 | 2019 | 6331 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Treatment Outcome | 10 | 2021 | 51732 | 0.06 | Why? |
| Brain | 1 | 2020 | 5133 | 0.06 | Why? |
| Granulomatosis with Polyangiitis | 1 | 2005 | 161 | 0.06 | Why? |
| Severity of Illness Index | 9 | 2021 | 48226 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.06 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.06 | Why? |
| Phosphorylation | 2 | 2019 | 1060 | 0.06 | Why? |
| Reactive Oxygen Species | 2 | 2019 | 1136 | 0.06 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2018 | 3051 | 0.06 | Why? |
| Sweden | 2 | 2019 | 1969 | 0.06 | Why? |
| Intermediate Filaments | 1 | 2021 | 77 | 0.05 | Why? |
| Glial Fibrillary Acidic Protein | 1 | 2021 | 138 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.05 | Why? |
| Postoperative Complications | 1 | 2019 | 5861 | 0.05 | Why? |
| Mannose-Binding Lectin | 1 | 2020 | 131 | 0.05 | Why? |
| Neurofilament Proteins | 1 | 2021 | 202 | 0.05 | Why? |
| Mice, Inbred C57BL | 3 | 2019 | 5542 | 0.05 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.05 | Why? |
| Myocytes, Cardiac | 1 | 2006 | 804 | 0.05 | Why? |
| Mutation | 2 | 2017 | 12376 | 0.05 | Why? |
| Antigen-Antibody Complex | 1 | 2021 | 408 | 0.05 | Why? |
| Acute-Phase Proteins | 1 | 2020 | 177 | 0.05 | Why? |
| Interleukin-2 Receptor alpha Subunit | 1 | 2020 | 234 | 0.05 | Why? |
| Survival Rate | 3 | 2019 | 9206 | 0.05 | Why? |
| Occupational Exposure | 1 | 2018 | 4742 | 0.05 | Why? |
| Pregnancy | 6 | 2019 | 23879 | 0.05 | Why? |
| Frizzled Receptors | 1 | 2018 | 6 | 0.05 | Why? |
| Intention to Treat Analysis | 1 | 2020 | 673 | 0.05 | Why? |
| Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2018 | 6 | 0.05 | Why? |
| Scandinavian and Nordic Countries | 1 | 2018 | 96 | 0.05 | Why? |
| Syndecan-1 | 1 | 2018 | 65 | 0.05 | Why? |
| Receptors, LH | 1 | 2018 | 6 | 0.05 | Why? |
| Mozambique | 1 | 2018 | 205 | 0.05 | Why? |
| Bone Morphogenetic Proteins | 1 | 2018 | 25 | 0.05 | Why? |
| Diet, High-Fat | 1 | 2019 | 161 | 0.05 | Why? |
| Neutrophil Activation | 1 | 2002 | 510 | 0.05 | Why? |
| Cross-Sectional Studies | 7 | 2019 | 53120 | 0.05 | Why? |
| Apolipoprotein B-100 | 1 | 2017 | 18 | 0.05 | Why? |
| Endothelial Protein C Receptor | 1 | 2018 | 32 | 0.04 | Why? |
| Heart Defects, Congenital | 1 | 2008 | 933 | 0.04 | Why? |
| Sterol Esterase | 1 | 2017 | 4 | 0.04 | Why? |
| Bundle-Branch Block | 1 | 2019 | 127 | 0.04 | Why? |
| Receptors, Interleukin | 1 | 2018 | 83 | 0.04 | Why? |
| Apyrase | 1 | 2017 | 39 | 0.04 | Why? |
| Endostatins | 1 | 2017 | 4 | 0.04 | Why? |
| Properdin | 1 | 2017 | 1 | 0.04 | Why? |
| Echocardiography | 3 | 2019 | 3661 | 0.04 | Why? |
| Calmodulin-Binding Proteins | 1 | 2017 | 6 | 0.04 | Why? |
| RNA-Binding Protein EWS | 1 | 2017 | 3 | 0.04 | Why? |
| Islets of Langerhans Transplantation | 1 | 2018 | 41 | 0.04 | Why? |
| STAT6 Transcription Factor | 1 | 2017 | 28 | 0.04 | Why? |
| Metabolism | 1 | 2018 | 74 | 0.04 | Why? |
| Lipopolysaccharide Receptors | 1 | 2020 | 357 | 0.04 | Why? |
| Registries | 1 | 2018 | 12327 | 0.04 | Why? |
| Receptors, Cytokine | 1 | 2017 | 75 | 0.04 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.04 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2018 | 6653 | 0.04 | Why? |
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2017 | 33 | 0.04 | Why? |
| Muscle Proteins | 1 | 2017 | 64 | 0.04 | Why? |
| Minor Histocompatibility Antigens | 1 | 2017 | 56 | 0.04 | Why? |
| Receptors, IgE | 1 | 2017 | 26 | 0.04 | Why? |
| 5-Methylcytosine | 1 | 2017 | 16 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.04 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
| Syk Kinase | 1 | 2017 | 32 | 0.04 | Why? |
| Adverse Outcome Pathways | 1 | 2017 | 63 | 0.04 | Why? |
| Complement Factor H | 1 | 2017 | 83 | 0.04 | Why? |
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2017 | 92 | 0.04 | Why? |
| STAT Transcription Factors | 1 | 2017 | 173 | 0.04 | Why? |
| Myofibroblasts | 1 | 2017 | 61 | 0.04 | Why? |
| Diastole | 1 | 2017 | 168 | 0.04 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2017 | 85 | 0.04 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.04 | Why? |
| Heart Function Tests | 1 | 2017 | 101 | 0.04 | Why? |
| Genetic Markers | 1 | 2018 | 318 | 0.04 | Why? |
| Galectin 3 | 1 | 2017 | 76 | 0.04 | Why? |
| Absorptiometry, Photon | 1 | 2017 | 168 | 0.04 | Why? |
| Galectins | 1 | 2017 | 109 | 0.04 | Why? |
| Interleukin-12 | 1 | 2017 | 156 | 0.04 | Why? |
| Fatty Acids | 1 | 2017 | 238 | 0.04 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.04 | Why? |
| Pulse Wave Analysis | 1 | 2017 | 221 | 0.04 | Why? |
| Gene Expression Profiling | 2 | 2018 | 3788 | 0.04 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2018 | 253 | 0.04 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Homeostasis | 1 | 2019 | 582 | 0.04 | Why? |
| Phenotype | 2 | 2017 | 4037 | 0.04 | Why? |
| Graft Survival | 1 | 2018 | 587 | 0.04 | Why? |
| Drug Therapy, Combination | 2 | 2020 | 7268 | 0.04 | Why? |
| Arginine | 1 | 2018 | 377 | 0.04 | Why? |
| Collagen | 1 | 2017 | 222 | 0.04 | Why? |
| Chromatography, Liquid | 1 | 2018 | 640 | 0.04 | Why? |
| Proteolysis | 1 | 2019 | 751 | 0.04 | Why? |
| Plasmodium falciparum | 1 | 2018 | 337 | 0.04 | Why? |
| Risk Assessment | 5 | 2018 | 25439 | 0.04 | Why? |
| Janus Kinase 1 | 1 | 2017 | 254 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.04 | Why? |
| Allografts | 1 | 2018 | 761 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.03 | Why? |
| Endothelium | 1 | 2018 | 460 | 0.03 | Why? |
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2013 | 12 | 0.03 | Why? |
| Statistics, Nonparametric | 2 | 2008 | 1008 | 0.03 | Why? |
| Biopterin | 1 | 1993 | 8 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| MAP Kinase Signaling System | 1 | 2017 | 360 | 0.03 | Why? |
| Connective Tissue Diseases | 1 | 2017 | 187 | 0.03 | Why? |
| Triglycerides | 1 | 2017 | 478 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2018 | 604 | 0.03 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.03 | Why? |
| Oxidation-Reduction | 1 | 2017 | 540 | 0.03 | Why? |
| Troponin | 1 | 2020 | 1058 | 0.03 | Why? |
| Catheter Ablation | 1 | 2019 | 438 | 0.03 | Why? |
| Standard of Care | 1 | 2021 | 1297 | 0.03 | Why? |
| Methylprednisolone | 1 | 2005 | 2107 | 0.03 | Why? |
| Receptors, Retinoic Acid | 1 | 2013 | 39 | 0.03 | Why? |
| beta 2-Microglobulin | 1 | 1993 | 102 | 0.03 | Why? |
| CD8 Antigens | 1 | 1993 | 72 | 0.03 | Why? |
| ADP-ribosyl Cyclase 1 | 1 | 2013 | 96 | 0.03 | Why? |
| Cholesterol, HDL | 1 | 2016 | 439 | 0.03 | Why? |
| Ultrasonography, Interventional | 1 | 2018 | 560 | 0.03 | Why? |
| Disease Progression | 3 | 2019 | 13580 | 0.03 | Why? |
| Th2 Cells | 1 | 2017 | 680 | 0.03 | Why? |
| Blood Proteins | 1 | 2017 | 551 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| CD4-CD8 Ratio | 1 | 2013 | 235 | 0.03 | Why? |
| Microcirculation | 1 | 2017 | 447 | 0.03 | Why? |
| Duodenum | 1 | 1993 | 179 | 0.03 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.03 | Why? |
| Tandem Mass Spectrometry | 1 | 2018 | 1031 | 0.03 | Why? |
| Exercise Test | 1 | 2019 | 911 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.03 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2017 | 724 | 0.03 | Why? |
| Immunophenotyping | 1 | 2017 | 1290 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2019 | 9893 | 0.03 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2017 | 881 | 0.03 | Why? |
| Mitochondria | 1 | 2019 | 857 | 0.03 | Why? |
| Lung | 2 | 2018 | 31049 | 0.03 | Why? |
| Repressor Proteins | 1 | 2013 | 232 | 0.03 | Why? |
| Weight Loss | 1 | 2017 | 826 | 0.03 | Why? |
| DNA Methylation | 1 | 2017 | 688 | 0.03 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2019 | 2437 | 0.03 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.03 | Why? |
| Liver | 2 | 2019 | 4007 | 0.03 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Membrane Glycoproteins | 1 | 2020 | 2273 | 0.03 | Why? |
| Placenta | 1 | 2002 | 1531 | 0.03 | Why? |
| Th1 Cells | 1 | 2017 | 1228 | 0.03 | Why? |
| Insulin | 1 | 2019 | 1316 | 0.03 | Why? |
| Plasma Cells | 1 | 2013 | 464 | 0.03 | Why? |
| Biological Specimen Banks | 1 | 2018 | 1142 | 0.03 | Why? |
| Homosexuality | 1 | 1989 | 16 | 0.02 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.02 | Why? |
| Blood Pressure | 1 | 2001 | 2198 | 0.02 | Why? |
| RNA-Binding Proteins | 1 | 2017 | 1022 | 0.02 | Why? |
| Metronidazole | 1 | 1989 | 59 | 0.02 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.02 | Why? |
| Glucocorticoids | 1 | 2005 | 4431 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 13720 | 0.02 | Why? |
| Microbiota | 1 | 2019 | 1240 | 0.02 | Why? |
| 4-1BB Ligand | 1 | 2008 | 9 | 0.02 | Why? |
| Comorbidity | 3 | 2019 | 34796 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Child | 5 | 2019 | 70012 | 0.02 | Why? |
| Calcinosis | 1 | 2011 | 240 | 0.02 | Why? |
| Complementary Therapies | 1 | 1992 | 280 | 0.02 | Why? |
| Coronary Angiography | 1 | 2018 | 2275 | 0.02 | Why? |
| Troponin I | 1 | 2017 | 1298 | 0.02 | Why? |
| High-Throughput Screening Assays | 1 | 2017 | 1783 | 0.02 | Why? |
| Heart-Assist Devices | 1 | 2017 | 812 | 0.02 | Why? |
| Immunomodulation | 1 | 2017 | 1472 | 0.02 | Why? |
| Proteomics | 1 | 2019 | 2481 | 0.02 | Why? |
| Endocrine System | 1 | 2008 | 67 | 0.02 | Why? |
| Flow Cytometry | 1 | 2016 | 2393 | 0.02 | Why? |
| Cell Enlargement | 1 | 2006 | 3 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.02 | Why? |
| Drug Antagonism | 1 | 2006 | 24 | 0.02 | Why? |
| Renal Artery | 1 | 2008 | 66 | 0.02 | Why? |
| Smad2 Protein | 1 | 2006 | 20 | 0.02 | Why? |
| Cell Differentiation | 1 | 2013 | 1338 | 0.02 | Why? |
| Lung Transplantation | 1 | 2018 | 1554 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.02 | Why? |
| Smad3 Protein | 1 | 2006 | 40 | 0.02 | Why? |
| Perfusion | 1 | 2008 | 254 | 0.02 | Why? |
| Apolipoproteins E | 1 | 2008 | 170 | 0.02 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.02 | Why? |
| Bariatric Surgery | 1 | 2017 | 1298 | 0.02 | Why? |
| Interleukin-10 | 1 | 2013 | 1409 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Hypercholesterolemia | 1 | 2008 | 175 | 0.02 | Why? |
| Cardiomegaly | 1 | 2006 | 96 | 0.02 | Why? |
| Endothelial Cells | 1 | 2016 | 2048 | 0.02 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.02 | Why? |
| Body Mass Index | 1 | 2019 | 4306 | 0.02 | Why? |
| Bone and Bones | 1 | 2008 | 235 | 0.02 | Why? |
| Radiography | 1 | 2013 | 1576 | 0.02 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.02 | Why? |
| Histocompatibility Antigens Class II | 1 | 2008 | 383 | 0.02 | Why? |
| Enterotoxins | 1 | 2005 | 115 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2016 | 4758 | 0.02 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 2309 | 0.02 | Why? |
| Feces | 1 | 2018 | 4235 | 0.02 | Why? |
| Chloroquine | 1 | 2019 | 3152 | 0.02 | Why? |
| Regression Analysis | 1 | 2011 | 2484 | 0.02 | Why? |
| Probability | 1 | 2008 | 923 | 0.02 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| Cohort Studies | 2 | 2017 | 36005 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Receptors, Complement | 1 | 2002 | 15 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.02 | Why? |
| CD55 Antigens | 1 | 2002 | 14 | 0.02 | Why? |
| L-Selectin | 1 | 2002 | 42 | 0.01 | Why? |
| Integrin alpha4 | 1 | 2002 | 21 | 0.01 | Why? |
| Immunoassay | 1 | 2018 | 4485 | 0.01 | Why? |
| Genetic Predisposition to Disease | 1 | 2016 | 4027 | 0.01 | Why? |
| Uterus | 1 | 2002 | 98 | 0.01 | Why? |
| Percutaneous Coronary Intervention | 1 | 2018 | 3646 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.01 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.01 | Why? |
| Incidence | 2 | 2017 | 25622 | 0.01 | Why? |
| Plant Extracts | 1 | 1992 | 1514 | 0.01 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Antibody Formation | 1 | 2013 | 4038 | 0.01 | Why? |
| Hypertension | 1 | 2001 | 8895 | 0.01 | Why? |
| Rats | 1 | 2006 | 2764 | 0.01 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.01 | Why? |
| Staphylococcus aureus | 1 | 2005 | 844 | 0.01 | Why? |
| Immune System | 1 | 2008 | 1479 | 0.01 | Why? |
| Temperature | 1 | 2008 | 2305 | 0.01 | Why? |
| Multivariate Analysis | 1 | 2008 | 5440 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Creatinine | 1 | 2001 | 1443 | 0.01 | Why? |
| IgG Deficiency | 1 | 1993 | 22 | 0.01 | Why? |
| Cardiac Surgical Procedures | 1 | 2008 | 1931 | 0.01 | Why? |
| Plant Poisoning | 1 | 1992 | 1 | 0.01 | Why? |
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1993 | 102 | 0.01 | Why? |
| CD3 Complex | 1 | 1993 | 237 | 0.01 | Why? |
| Immunoglobulin G | 2 | 2013 | 21571 | 0.01 | Why? |
| CD4 Antigens | 1 | 1993 | 306 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Infant | 1 | 2008 | 30274 | 0.00 | Why? |
| Child, Preschool | 1 | 1993 | 36283 | 0.00 | Why? |